pbm glp-1 news Eli Lilly Coverage: CMO Capacity & GMP Impact Drug Channels: Drug Channels News

There is no pharmacological benefit to combining Melanotan-1 with oral tanning accelerators (typically beta-carotene, tyrosine, or PABA-based supplements) because the peptide directly activates melanocytes through MC1R receptor binding adding precursor molecules does not enhance melanogenesis beyond the saturation point already achieved by receptor activation

Originally, GLP-1 medications were only available as injections

doi: 10.1002/rth2.12283 19 EstvezF.De AngeloT.VesellE

Willis et al

An early clinical report in 1994 described significant clinical improvements in patients treated with DFO (Duarte-Silva et al., 2025)